Harvard Law Professor Glenn Cohen has been elected to the National School of Medicine – Harvard Law School

I. Glenn Cohen ’03, James A. Attwood and Leslie Williams Professor of Law and associate professor at Harvard Law School, has been elected to the prestigious National Academy of Medicine.

Admission to this school is considered one of the highest honors in the fields of health and medicine and recognizes people who have made a significant contribution to the development of medical science, health care and life. public good.

Cohen, one of the world’s leading experts on the intersection of health care, bioethics and law, has received international acclaim for organizing major scholarly collaborations.

Cohen has focused his research on bioethics and health law in the United States and around the world, including pioneering work in AI/big data and health, abortion, reproductive rights and technology, the therapeutic use of psychedelics, and LGBTQ rights. As faculty director of Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics, he oversees a world-renowned research center dedicated to promoting interdisciplinary analysis and policy legal education. of health law, biotechnology and bioethics.

He was one of 100 new members in the United States and 10 abroad who were elected to the academy during the NAM’s annual meeting this fall.

“I am very proud to be a member of NAM, an organization that I love and have worked closely with for years.” Cohen said. As with any such important event, it would not have been possible without the amazing mentorship I received in the field from those within the law school, such as Einer Elhauge, and those outside it, including Bernie Lo, Bill Sage, Judy Daar, Eli Adashi, Mark Hall, the late Dan Brock and many others. “

Cohen is the author, co-author, editor, or co-editor of more than 20 books, including “COVID-19 and the Law” (Cambridge University Press, 2023); “Reproductive Technologies and the Law” (Caroline Academic Press, 2022); “The Future of Medical Device Regulation” (Cambridge University Press, 2022); and “Consumer Genetic Technologies: Ethics and Legal Management” (Cambridge University Press, 2021). He is also the author of over 200 articles and chapters in leading legal, scientific, medical, public health and bioethics journals.

Cohen advised the vice president of the United States on reproductive rights, discussed medical AI policy with members of the Korean Congress, and spoke at legal, medical, and industry conferences around the world. .

He has served on the Ethics Committee for the Canadian Institutes of Health Research, the Canadian counterpart to the NIH, and the Ethics Committee of the American College of Obstetricians and Gynecologists and the Ethics Committee of the US Organ Procurement and Transplantation Network.

He is a leading voice on health issues in the media and his work has been frequently quoted on, or featured in media outlets including PBS, NPR, ABC, NBC, CBS, CNN, The New York Times, The Washington Post, and The Boston. Earth.

The National Academy of Medicine, originally established as the Institute of Medicine in 1970 by the National Academy of Sciences, addresses critical issues in health, science, medicine, and related policy and promotes positive action in across branches.

New members are elected by current members in a manner that recognizes people who have made significant contributions to the development of medical science, health care and public health. At least a quarter of the academy’s members are appointed from fields outside the health professions, including fields such as law, engineering, social sciences and humanities.

The new elected members bring NAM’s total membership to over 2,400, which includes approximately 200 international members.

In addition to Cohen, Harvard fellows selected this year include:

Jonathan F. Bean, MD, MPH, professor, department of physical medicine and rehabilitation, Harvard Medical School; and director, New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System;

Bob S. Carter, MD, Ph.D., William and Elizabeth Sweet Professor of Neurosurgery, Harvard Medical School and Massachusetts General Hospital;

Leemore Dafny, Ph.D., Bruce V. Rauner Professor of Business Administration, Harvard Business School; and professor of public policy, Harvard Kennedy School;

Patricia C. Dykes, Ph.D., MA, RN, research program director, Center for Patient Safety, Research and Practice, Brigham and Women’s Hospital; and professor of medicine, Harvard Medical School;

Marcia Carmen Haigis, Ph.D., professor, department of cell biology, Harvard Medical School;

Nicole Maestas, MPP, Ph.D., John D. MacArthur Professor of Health Care Policy, Harvard Medical School;

David Pellman, MD, Howard Hughes Medical Institute investigator and professor of cell biology and pediatrics, Dana-Farber Cancer Center and Harvard Medical School;

Olivier Pourquié, Ph.D., Frank Burr Mallory Professor, department of pathology, Brigham and Women’s Hospital, and department of genetics, Harvard Medical School;

Hao Wu, Ph.D., senior investigator, Program in Cellular and Molecular Medicine, Boston Children’s Hospital; and Asa and Patricia Springer Professor, department of biological chemistry and molecular pharmacology, Harvard Medical School

NAM works together with the National Academy of Sciences and the National Academy of Engineering to provide independent, objective assessment and advice to the public and undertake other activities to solve complex problems and inform public policy decisions.

Through their election, NAM members make a commitment to volunteer in the activities of the National Schools.

---

Want to stay up-to-date on Harvard Law Today? Sign up for our weekly newsletter.